UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4123) 4123
carcinoma, hepatocellular - enzymology (3555) 3555
science & technology (3535) 3535
life sciences & biomedicine (3252) 3252
liver neoplasms - enzymology (2861) 2861
animals (2852) 2852
male (2120) 2120
female (1703) 1703
rats (1598) 1598
carcinoma, hepatocellular - pathology (1543) 1543
liver neoplasms - pathology (1412) 1412
liver - enzymology (1348) 1348
oncology (1347) 1347
biological and medical sciences (1305) 1305
hepatocellular carcinoma (1222) 1222
cell line, tumor (1168) 1168
middle aged (1164) 1164
tumors (1091) 1091
medical sciences (1058) 1058
mice (1022) 1022
liver neoplasms (907) 907
aged (872) 872
adult (813) 813
carcinoma, hepatocellular - genetics (813) 813
carcinoma, hepatocellular - metabolism (782) 782
liver neoplasms - genetics (735) 735
tumor cells, cultured (672) 672
liver cancer (654) 654
biochemistry & molecular biology (627) 627
cell biology (625) 625
cancer (607) 607
neoplasms, experimental - enzymology (605) 605
hepatoma (574) 574
liver neoplasms - metabolism (569) 569
apoptosis (549) 549
gastroenterology. liver. pancreas. abdomen (527) 527
immunohistochemistry (510) 510
gene expression (505) 505
gene expression regulation, neoplastic (501) 501
liver. biliary tract. portal circulation. exocrine pancreas (481) 481
proteins (469) 469
gastroenterology & hepatology (448) 448
carcinoma, hepatocellular - drug therapy (436) 436
transfection (431) 431
cell line (430) 430
prognosis (426) 426
carcinoma, hepatocellular (415) 415
cell proliferation (415) 415
time factors (415) 415
research article (413) 413
research (408) 408
enzymes (405) 405
liver neoplasms - drug therapy (391) 391
kinetics (387) 387
analysis (384) 384
liver (376) 376
signal transduction (374) 374
metastasis (344) 344
apoptosis - drug effects (343) 343
hep g2 cells (332) 332
mice, nude (332) 332
kinases (329) 329
pharmacology & pharmacy (319) 319
neoplasm invasiveness (312) 312
phosphorylation (310) 310
rna, messenger - metabolism (302) 302
fundamental and applied biological sciences. psychology (300) 300
liver - metabolism (292) 292
blotting, western (286) 286
pathology (286) 286
digestive system diseases (282) 282
science & technology - other topics (280) 280
gene expression regulation, enzymologic (277) 277
medicine (276) 276
multidisciplinary sciences (275) 275
genetic aspects (274) 274
cell proliferation - drug effects (273) 273
dose-response relationship, drug (271) 271
aged, 80 and over (269) 269
base sequence (267) 267
rna, messenger - genetics (263) 263
antineoplastic agents - pharmacology (260) 260
molecular sequence data (252) 252
development and progression (246) 246
liver - pathology (244) 244
medicine, research & experimental (243) 243
research & experimental medicine (243) 243
abridged index medicus (240) 240
health aspects (238) 238
reverse transcriptase polymerase chain reaction (238) 238
neoplasm transplantation (236) 236
liver - drug effects (230) 230
risk factors (226) 226
science (223) 223
enzyme activation (220) 220
mice, inbred balb c (216) 216
signal transduction - drug effects (216) 216
cell cycle (214) 214
cell growth (212) 212
mutation (210) 210
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5663) 5663
Russian (115) 115
Japanese (108) 108
Chinese (90) 90
German (42) 42
French (38) 38
Italian (9) 9
Polish (7) 7
Spanish (6) 6
Hungarian (4) 4
Portuguese (3) 3
Korean (2) 2
Croatian (1) 1
Dutch (1) 1
Romanian (1) 1
Swedish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer cell, ISSN 1535-6108, 2011, Volume 19, Issue 5, pp. 629 - 639
Oncology | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Protein Tyrosine Phosphatase, Non-Receptor Type 11 - metabolism | Carcinoma, Hepatocellular - chemically induced | Liver - pathology | Hepatitis - enzymology | Liver - enzymology | Carcinoma, Hepatocellular - prevention & control | Humans | Hyperplasia | Lipopolysaccharides - administration & dosage | Adenoma, Liver Cell - pathology | Liver Neoplasms - chemically induced | Male | Necrosis | Liver - drug effects | Time Factors | Tumor Suppressor Proteins - deficiency | Carcinoma, Hepatocellular - genetics | Diethylnitrosamine | Hepatitis - genetics | Protein Tyrosine Phosphatase, Non-Receptor Type 11 - deficiency | Tumor Suppressor Proteins - genetics | STAT3 Transcription Factor - deficiency | Liver Neoplasms - pathology | Adenoma, Liver Cell - enzymology | Liver Neoplasms - enzymology | Cytokines - genetics | Interleukin-6 - administration & dosage | Adenoma, Liver Cell - genetics | STAT3 Transcription Factor - genetics | Cytokines - blood | Liver Neoplasms - prevention & control | Liver Regeneration | Tumor Suppressor Proteins - metabolism | Liver Neoplasms - genetics | Signal Transduction | Mice, Inbred C57BL | Gene Expression Regulation | Inflammation Mediators - blood | Hepatitis - pathology | Protein Tyrosine Phosphatase, Non-Receptor Type 11 - analysis | Carcinoma, Hepatocellular - enzymology | Mice, Knockout | Animals | Carcinoma, Hepatocellular - pathology | Mice | Protein Tyrosine Phosphatase, Non-Receptor Type 11 - genetics | Tyrosine | Liver cancer | Development and progression | Phosphatases | Leukemia | Index Medicus
Journal Article
European journal of cancer (1990), ISSN 0959-8049, 2013, Volume 49, Issue 16, pp. 3412 - 3419
Hematology, Oncology and Palliative Medicine | Second line | Regorafenib | Hepatocellular carcinoma | Tolerability | Safety | Receptor kinase inhibition | Safety Second line | Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Pharmacology. Drug treatments | Tumors | Carcinoma, Hepatocellular - mortality | Humans | Middle Aged | Pyridines - pharmacokinetics | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Protein Kinase Inhibitors - adverse effects | Liver Neoplasms - mortality | Pyridines - adverse effects | Carcinoma, Hepatocellular - drug therapy | Time Factors | Antineoplastic Agents - adverse effects | Phenylurea Compounds - adverse effects | Adult | Female | Liver Neoplasms - pathology | Antineoplastic Agents - pharmacokinetics | Phenylurea Compounds - pharmacokinetics | Liver Neoplasms - enzymology | Pyridines - therapeutic use | Protein Kinase Inhibitors - pharmacokinetics | Pyridines - administration & dosage | Drug Administration Schedule | Europe | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Phenylurea Compounds - therapeutic use | Treatment Outcome | Carcinoma, Hepatocellular - enzymology | Disease Progression | Protein Kinase Inhibitors - administration & dosage | Phenylurea Compounds - administration & dosage | Asia | Protein Kinase Inhibitors - therapeutic use | Carcinoma, Hepatocellular - pathology | Aged | Neoplasm Staging | Care and treatment | Safety and security measures | Hepatoma | Index Medicus
Journal Article
World journal of gastroenterology : WJG, ISSN 1007-9327, 11/2013, Volume 19, Issue 41, pp. 6969 - 6978
Liver disease | Patatin-like phospholipase domain-containing 3 | Chronic hepatitis C virus hepatitis | Genetics | Hepatocellular carcinoma | Nonalcoholic fatty liver disease | Single nucleotide polymorphism | Fibrogenesis | Alcoholic liver disease | Steatosis | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Cholangitis, Sclerosing - enzymology | Hepatitis C, Chronic - pathology | Fatty Liver - pathology | Humans | Cholangitis, Sclerosing - genetics | Fatty Liver - complications | Hepatitis B, Chronic - enzymology | Hepatitis C, Chronic - complications | Liver Cirrhosis - enzymology | Hemochromatosis - pathology | Fatty Liver, Alcoholic - genetics | Hepatitis B, Chronic - genetics | Liver Cirrhosis, Alcoholic - enzymology | Hepatitis C, Chronic - enzymology | Fatty Liver - enzymology | Non-alcoholic Fatty Liver Disease | Liver Neoplasms - pathology | Fatty Liver, Alcoholic - pathology | Liver Neoplasms - enzymology | Fatty Liver, Alcoholic - enzymology | Hepatitis B, Chronic - pathology | Liver Cirrhosis - genetics | Hemochromatosis - genetics | Fatty Liver - genetics | Genetic Predisposition to Disease | Liver Neoplasms - genetics | Liver Cirrhosis, Alcoholic - pathology | Membrane Proteins - genetics | Risk Factors | Hemochromatosis - enzymology | Disease Progression | Polymorphism, Genetic | Cholangitis, Sclerosing - pathology | Fatty Liver, Alcoholic - complications | Liver Cirrhosis, Alcoholic - genetics | Phenotype | Liver Cirrhosis - pathology | Carcinoma, Hepatocellular | Hepatitis C, Chronic - genetics | Lipase - genetics | Index Medicus | Review | Gastroenterologi | CHRONIC HEPATITIS-C | NONALCOHOLIC STEATOHEPATITIS | Hepatocellular | GREATER-THAN-G | B-VIRUS INFECTION | HEPATOCELLULAR-CARCINOMA | INSULIN-RESISTANCE | FATTY LIVER | DOMAIN-CONTAINING 3 | GENETIC VARIANT | Gastroenterology and Hepatology | GENOME-WIDE ASSOCIATION
Journal Article
Cancer cell, ISSN 1535-6108, 04/2014, Volume 25, Issue 4, pp. 428 - 441
Journal Article
Cancer letters, ISSN 0304-3835, 2015, Volume 367, Issue 1, pp. 1 - 11
Journal Article